Saved in:
| Main Author: | G. Sgalla |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Sociedade Portuguesa de Pneumologia
2017
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=169752768002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?
by: S. Campainha
Published: (2016)
by: S. Campainha
Published: (2016)
Clinical impact of a multidisciplinary discussion group on the diagnosis of idiopathic pulmonary fibrosis in Colombia
by: MAURICIO GONZÁLEZ-GARCÍA
Published: (2022)
by: MAURICIO GONZÁLEZ-GARCÍA
Published: (2022)
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
by: Zezhou Shi, et al.
Published: (2024)
by: Zezhou Shi, et al.
Published: (2024)
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
by: C. Robalo-Cordeiro
Published: (2017)
by: C. Robalo-Cordeiro
Published: (2017)
Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
by: Yuichi Nagata, et al.
Published: (2024)
by: Yuichi Nagata, et al.
Published: (2024)
Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis
by: Meghana Arvind, et al.
Published: (2024)
by: Meghana Arvind, et al.
Published: (2024)
Preoperative pulmonary function and respiratory muscle strength in Portuguese adolescents with idiopathic scoliosis
by: F. Flores
Published: (2016)
by: F. Flores
Published: (2016)
Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024)
by: Steven D. Nathan, et al.
Published: (2024)
The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation
by: Rosa K. Kortekaas, et al.
Published: (2024)
by: Rosa K. Kortekaas, et al.
Published: (2024)
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
by: John A. Mackintosh, et al.
Published: (2024)
by: John A. Mackintosh, et al.
Published: (2024)
Biosimilars and implications for pharmacy practice: Ready or not, here they come!
by: Andrea L. Hobbs
Published: (2019)
by: Andrea L. Hobbs
Published: (2019)
Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights.
by: Ma, Meiting, et al.
Published: (2025)
by: Ma, Meiting, et al.
Published: (2025)
Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape
by: Yajun Wang, et al.
Published: (2024)
by: Yajun Wang, et al.
Published: (2024)
Lichen planus pigmentosus‐like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis
by: Marijana Vičić, et al.
Published: (2024)
by: Marijana Vičić, et al.
Published: (2024)
Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
by: André Carramenha de Góes Hirano
Published: (2017)
by: André Carramenha de Góes Hirano
Published: (2017)
Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis. Joint Consensus of Sociedade Portuguesa de Pneumologia, Sociedade Portuguesa de Radiologia e Medicina Nuclear e Sociedade Portuguesa de Anatomia Patológica
by: C. Robalo Cordeiro
Published: (2016)
by: C. Robalo Cordeiro
Published: (2016)
Effects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisolone
by: Z.A. Aytemur
Published: (2012)
by: Z.A. Aytemur
Published: (2012)
Proinflammatory S100 proteins as clinical markers of juvenile idiopathic arthritis
by: Skirmantė Rusonienė
Published: (2014)
by: Skirmantė Rusonienė
Published: (2014)
Evaluating the robustness of deep learning models trained to diagnose idiopathic pulmonary fibrosis using a retrospective study
by: Wenxi Yu, et al.
Published: (2025)
by: Wenxi Yu, et al.
Published: (2025)
What is the clinical significance of isolated subsegmental pulmonary embolism?
by: M.A. Gómez-Sánchez
Published: (2014)
by: M.A. Gómez-Sánchez
Published: (2014)
Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
by: Lei Yao, et al.
Published: (2024)
by: Lei Yao, et al.
Published: (2024)
The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
by: Yichao Zhao, et al.
Published: (2024)
by: Yichao Zhao, et al.
Published: (2024)
Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
by: Ying Zhang, et al.
Published: (2024)
by: Ying Zhang, et al.
Published: (2024)
The frequency of lung cancer in patients with pulmonary hamartomas: An evaluation of clinical, radiological, and pathological features and follow-up data of 96 patients with pulmonary hamartomas
by: G.H. Ekinci
Published: (2017)
by: G.H. Ekinci
Published: (2017)
Theory generation: from evidence to practice
by: Equipo organizador del Primer Congreso Internacional de Enfermería
Published: (2013)
by: Equipo organizador del Primer Congreso Internacional de Enfermería
Published: (2013)
A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress‐related genes
by: Bin Liu, et al.
Published: (2024)
by: Bin Liu, et al.
Published: (2024)
The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview
by: A. Robalo Nunes
Published: (2017)
by: A. Robalo Nunes
Published: (2017)
Prescribing exercise training in pulmonary rehabilitation: A clinical experience
by: S. Bernard
Published: (2014)
by: S. Bernard
Published: (2014)
Dashed dreams: Climate change comes for the middle class
by: Colin Jerolmack
Published: (2024)
by: Colin Jerolmack
Published: (2024)
Endoscopic ultrasound in clinical practice
by: Daniel Keter
Published: (2008)
by: Daniel Keter
Published: (2008)
Children with pulmonary atelectasis: clinical outcome and characterization of physical therapy
by: Carolina Cotrim Dal Pozzo
Published: (2013)
by: Carolina Cotrim Dal Pozzo
Published: (2013)
Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis
by: Jamal Bousamaki, et al.
Published: (2025)
by: Jamal Bousamaki, et al.
Published: (2025)
Endomyocardial fibrosis
by: Paulo Sampaio Gutierrez
Published: (2017)
by: Paulo Sampaio Gutierrez
Published: (2017)
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort
by: Veronica Marcoux, et al.
Published: (2024)
by: Veronica Marcoux, et al.
Published: (2024)
And, what comes next?
by: María de los Ángeles Rodríguez Gázquez
Published: (2015)
by: María de los Ángeles Rodríguez Gázquez
Published: (2015)
Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
by: Viggo Rask Kragh Jorgensen
Published: (2006)
by: Viggo Rask Kragh Jorgensen
Published: (2006)
Using the internet to exchange information and experience on cystic fibrosis
by: Ellen Dayane Cargnin Pimentel
Published: (2013)
by: Ellen Dayane Cargnin Pimentel
Published: (2013)
The progress of brazilian neuropsychology. From research to clinical practice
by: Emmy Uehara
Published: (2016)
by: Emmy Uehara
Published: (2016)
The diagnostic yield of three clinical prediction rules for pulmonary embolism
by: Alirio Rodrigo Bastidas-Goyes
Published: (2020)
by: Alirio Rodrigo Bastidas-Goyes
Published: (2020)
A true dialytic urgency: lithium intoxication
by: Mariana Montoya-Castillo
Published: (2018)
by: Mariana Montoya-Castillo
Published: (2018)
Similar Items
-
Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?
by: S. Campainha
Published: (2016) -
Clinical impact of a multidisciplinary discussion group on the diagnosis of idiopathic pulmonary fibrosis in Colombia
by: MAURICIO GONZÁLEZ-GARCÍA
Published: (2022) -
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
by: Zezhou Shi, et al.
Published: (2024) -
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
by: C. Robalo-Cordeiro
Published: (2017) -
Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
by: Yuichi Nagata, et al.
Published: (2024)